灌注CT在鉴别胰腺导管腺癌与肿块型慢性胰腺炎及表征等密度胰腺病变中的效能
前瞻性研究纳入89例MDCT检出的胰腺病变并进一步行灌注CT分析,其中最终病理诊断为PDAC 61例、MFCP 12例。PDAC与MFCP相比BV、BF、PS更低而MTT更长(p<0.001);BV、BF、PS截断值分别为7.60 mL/100 mL、64.43 mL/100 mL/min、28.08 mL/100 mL/min时鉴别PDAC与MFCP的敏感度和特异度均为100%,MTT截断值7.47 s时敏感度98.3%、特异度80%。作者认为灌注CT有助于克服常规MDCT在诊断PDAC和表征等密度病变方面的局限。
要点
- PDAC与MFCP的BV、BF、PS均低于正常胰腺实质而MTT延长(p<0.05)。
- PDAC较MFCP的BV、BF、PS更低、MTT更长(p<0.001)。
- BV 7.60 mL/100 mL、BF 64.43 mL/100 mL/min、PS 28.08 mL/100 mL/min鉴别PDAC与MFCP的敏感度和特异度均为100%。
核心结论
- 灌注CT是可用于克服常规MDCT在诊断PDAC及表征等密度胰腺病变方面局限的技术。
研究设计与样本
- 前瞻性研究,纳入MDCT检出并经灌注CT进一步分析的胰腺病变89例,其中最终病理诊断为PDAC 61例、MFCP 12例,获取BV、BF、MTT、PS灌注图并比较病变与正常胰腺实质的灌注值。
关键影像表现/征象
- PDAC和MFCP的BV、BF、PS均低于正常胰腺实质,MTT长于正常胰腺实质(p<0.05)。
- PDAC的BV、BF、PS低于MFCP,MTT长于MFCP(p<0.001)。
- 等密度胰腺病变的BV、BF、PS低于正常胰腺实质,MTT长于正常胰腺实质(p<0.001)。
诊断标准与关键数值
- BV截断值7.60 mL/100 mL鉴别PDAC与MFCP,敏感度100%、特异度100%。
- BF截断值64.43 mL/100 mL/min鉴别PDAC与MFCP,敏感度100%、特异度100%。
- PS截断值28.08 mL/100 mL/min鉴别PDAC与MFCP,敏感度100%、特异度100%。
- MTT截断值7.47 s鉴别PDAC与MFCP,敏感度98.3%、特异度80%。
临床应用与阅片要点
- 对MDCT疑诊PDAC但难以与MFCP鉴别时,可参考灌注CT的BV、BF、PS及MTT参数辅助判别。
- 对MDCT上呈等密度的胰腺病变,灌注CT可显示其BV、BF、PS低于正常胰腺实质而MTT延长。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Multidetector computed tomography (MDCT) is routinely used in the diagnosis of pancreatic ductal adenocarcinoma (PDAC), but it may be inadequate in some cases, especially mass-forming chronic pancreatitis (MFCP) and isoattenuating pancreatic lesions. Perfusion CT (pCT) may help resolve this problem. The aim of this study was to evaluate whether pCT could help differentiating PDAC from MFCP and in characterization of isoattenuating pancreatic lesions.
MATERIALS AND METHODS: This prospective study included 89 cases of pancreatic lesions detected by MDCT and further analyzed with pCT. Sixty-one cases with final pathological diagnosis PDAC and 12 cases with MFCP were included from the study. Blood volume (BV), blood flow (BF), mean transit time (MTT), and permeability surface area product (PS) maps were obtained. Perfusion values obtained from the lesions and normal parenchyma were compared.
RESULTS: Compared with normal parenchyma, BV, BF, PS were lower and MTT was longer in PDAC and MFCP (p < 0.05). Compared with MFCP, BV, BF, PS were lower and MTT was longer in PDAC (p < 0.001). Compared with normal parenchyma, BV, BF, PS were lower and MTT was longer in isoattenuating lesions, (p < 0.001). Cutoff values of 7.60 mL/100 mL, 64.43 mL/100 mL/min, 28.08 mL/100 mL/min for BV, BF, PS, respectively, provided 100% sensitivity and specificity and 7.47 s for MTT provided 98.3% sensitivity, 80% specificity for distinguishing PDAC from MFCP.
CONCLUSION: pCT is a useful technology that can be helpful in overcoming the limitations of routine MDCT in diagnosing PDAC and characterization of isoattenuating lesions.
引用
- Aslan S, Nural MS, Camlidag I, et al. Efficacy of perfusion CT in differentiating of pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis and characterization of isoattenuating pancreatic lesions. Abdom Radiol (NY). 2019. PMID: 30225610. doi:10.1007/s00261-018-1776-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。